CL2008002859A1 - Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana. - Google Patents
Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana.Info
- Publication number
- CL2008002859A1 CL2008002859A1 CL2008002859A CL2008002859A CL2008002859A1 CL 2008002859 A1 CL2008002859 A1 CL 2008002859A1 CL 2008002859 A CL2008002859 A CL 2008002859A CL 2008002859 A CL2008002859 A CL 2008002859A CL 2008002859 A1 CL2008002859 A1 CL 2008002859A1
- Authority
- CL
- Chile
- Prior art keywords
- microbial cell
- cell
- permeabilizing
- vector
- signal peptide
- Prior art date
Links
- 230000000813 microbial effect Effects 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title abstract 3
- 108010076504 Protein Sorting Signals Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000008823 permeabilization Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- -1 POLIPEPTIDES Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000000696 methanogenic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
- Y02P60/22—Methane [CH4], e.g. from rice paddies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97510407P | 2007-09-25 | 2007-09-25 | |
| US98984007P | 2007-11-22 | 2007-11-22 | |
| US98984107P | 2007-11-22 | 2007-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008002859A1 true CL2008002859A1 (es) | 2009-03-06 |
Family
ID=40511642
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2008002860A CL2008002860A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido; polinucleotido que lo codifica; vector y fago aislado que comprenda este polinucleotido; anticuerpo que se une a este polipeptido; molecula de fusion que comprende este polipeptido; celula huesped metanogena que comprende el vector; composicion farmaceutica que comprende el polinucleotido. |
| CL2008002861A CL2008002861A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion. |
| CL2008002859A CL2008002859A1 (es) | 2007-09-25 | 2008-09-25 | Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2008002860A CL2008002860A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido; polinucleotido que lo codifica; vector y fago aislado que comprenda este polinucleotido; anticuerpo que se une a este polipeptido; molecula de fusion que comprende este polipeptido; celula huesped metanogena que comprende el vector; composicion farmaceutica que comprende el polinucleotido. |
| CL2008002861A CL2008002861A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion. |
Country Status (17)
| Country | Link |
|---|---|
| US (7) | US8592556B2 (enExample) |
| EP (5) | EP3327030B1 (enExample) |
| JP (5) | JP5558356B2 (enExample) |
| CN (4) | CN101918431B (enExample) |
| AR (3) | AR068553A1 (enExample) |
| AU (4) | AU2008304018A1 (enExample) |
| BR (5) | BR122021010729B1 (enExample) |
| CA (3) | CA2700164C (enExample) |
| CL (3) | CL2008002860A1 (enExample) |
| DK (3) | DK3327030T3 (enExample) |
| ES (3) | ES2895908T3 (enExample) |
| MX (3) | MX2010003321A (enExample) |
| NZ (1) | NZ745324A (enExample) |
| RU (1) | RU2528854C2 (enExample) |
| UY (3) | UY31360A1 (enExample) |
| WO (3) | WO2009041830A2 (enExample) |
| ZA (1) | ZA201001933B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ745324A (en) * | 2007-09-25 | 2023-02-24 | Pastoral Greenhouse Gas Res Ltd | Vaccines and vaccine components for inhibition of microbial cells |
| GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
| AU2010264659B2 (en) | 2009-06-26 | 2016-08-04 | Lysando Aktiengesellschaft | Antimicrobial agents |
| SI2445515T1 (sl) * | 2009-06-26 | 2016-08-31 | Lysando Ag | Antimikrobna sredstva |
| AU2010287069B2 (en) | 2009-08-27 | 2016-07-07 | Lucidome Bio Limited | Complete genome sequence of the methanogen Methanobrevibacter ruminantium |
| WO2011134998A1 (en) * | 2010-04-27 | 2011-11-03 | Lysando Holding Ag | Method of reducing biofilms |
| EP3736282B1 (en) * | 2012-09-19 | 2023-06-21 | Gemvax & Kael Co., Ltd. | Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate |
| EP4234696A3 (en) * | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
| KR102271291B1 (ko) | 2013-03-15 | 2021-07-02 | 더 제너럴 하스피탈 코포레이션 | 특정 게놈 좌위에 대한 유전적 및 후성적 조절 단백질의 rna-안내 표적화 |
| US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| US10011850B2 (en) | 2013-06-21 | 2018-07-03 | The General Hospital Corporation | Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing |
| EP3066201B1 (en) | 2013-11-07 | 2018-03-07 | Editas Medicine, Inc. | Crispr-related methods and compositions with governing grnas |
| DK3597740T3 (da) * | 2014-11-06 | 2022-06-20 | Dupont Us Holding Llc | Peptidmedieret indføring af rna-styret endonuklease i celler |
| CN104789675A (zh) * | 2015-04-15 | 2015-07-22 | 江苏师范大学 | 一种检测荷斯坦奶牛瘤胃微生物的方法 |
| CN108026566A (zh) * | 2015-05-04 | 2018-05-11 | 特拉维夫大学拉莫特有限公司 | 用于使dna片段化的方法和试剂盒 |
| US9512446B1 (en) | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| DK3484996T3 (da) * | 2016-07-14 | 2020-12-07 | Basf Se | Fermenteringsmedium, der omfatter et chelateringsmiddel |
| CA3048863A1 (en) * | 2016-12-29 | 2018-07-05 | Illumina, Inc. | Analysis system for orthogonal access to and tagging of biomolecules in cellular compartments |
| WO2018126499A1 (zh) * | 2017-01-05 | 2018-07-12 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物 |
| US10745439B2 (en) * | 2017-03-20 | 2020-08-18 | Regents Of The University Of Minnesota | Kinase substrates and methods of use thereof |
| US20190233816A1 (en) | 2018-01-26 | 2019-08-01 | Massachusetts Institute Of Technology | Structure-guided chemical modification of guide rna and its applications |
| EP3592140A1 (en) * | 2018-03-19 | 2020-01-15 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems |
| WO2020102603A1 (en) | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Engineered cd25 polypeptides and uses thereof |
| EP3880227A4 (en) | 2018-11-14 | 2022-11-09 | RubrYc Therapeutics, Inc. | ANTI-CD25 ANTIBODIES |
| CN109627301B (zh) * | 2019-02-18 | 2022-08-05 | 浙江新银象生物工程有限公司 | Nisin固体稳定剂开发及应用 |
| BR112022018599A2 (pt) * | 2020-03-19 | 2022-12-20 | Micreos Human Health Bv | Uma proteína de interesse estabilizada |
| US20230072496A1 (en) * | 2020-04-10 | 2023-03-09 | Liberty Biosecurity, Llc | Polypeptide compositions and uses thereof |
| CN112143747B (zh) * | 2020-09-09 | 2022-09-13 | 昆明理工大学 | 一种噬菌体裂解酶及其基因、基因重组表达载体与应用 |
| EP4037666B1 (en) | 2020-12-08 | 2024-05-01 | Ruminant Biotech Corp Limited | Improvements to devices and methods for delivery of substances to animals |
| CN112961217B (zh) * | 2021-03-19 | 2022-11-08 | 江苏元本生物科技有限公司 | 一种靶向Siglec-15的噬菌体多肽 |
| CN113121705B (zh) * | 2021-04-19 | 2023-03-24 | 成都英普博集生物科技有限公司 | 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用 |
| US20240009291A1 (en) * | 2022-07-11 | 2024-01-11 | Arkea Bio Corp. | Compositions and methods for reducing methane emissions in ruminant populations |
| CN115417927A (zh) * | 2022-09-08 | 2022-12-02 | 南京松天盛科生物科技有限公司 | 小鼠腹水致敏物及其应用 |
| WO2024097397A1 (en) * | 2022-11-03 | 2024-05-10 | Helix Nanotechnologies, Inc. | Ruminal and methanogen vaccines and uses thereof |
| CN115938486B (zh) * | 2022-12-06 | 2023-11-10 | 内蒙古农业大学 | 基于图神经网络的抗菌性乳酸菌株筛选方法 |
| WO2025219570A1 (en) | 2024-04-17 | 2025-10-23 | Johannes Kepler Universität Linz | Composition for inhibiting protein translocation and methods using the same |
| WO2025233675A1 (en) * | 2024-05-10 | 2025-11-13 | Institut Pasteur | Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US159861A (en) * | 1875-02-16 | Improvement in brooms | ||
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| WO1984004249A2 (fr) * | 1983-05-03 | 1984-11-08 | Ssm Int Chem Co Ltd | Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires |
| GB8815968D0 (en) * | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Veterinary devices |
| JPH05219927A (ja) * | 1992-02-14 | 1993-08-31 | Gumma Pref Gov | 飼料の混合装置及び混合飼料の製造方法 |
| JP3651915B2 (ja) * | 1993-06-30 | 2005-05-25 | 財団法人神奈川科学技術アカデミー | シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター |
| PT724454E (pt) * | 1993-10-19 | 2004-08-31 | Commw Scient Ind Res Org | Metodo para melhorar a utilizacao de nutrientes pelos animais ruminantes ou semelhantes a ruminantes |
| EP0730663B1 (en) | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| DK0739198T3 (da) | 1994-01-20 | 2004-01-26 | Agres Ltd | Anordning til indgivelse af gavnlige materialer til drøvtyggere |
| NZ278977A (en) | 1994-01-20 | 1997-03-24 | Pastoral Agric Res Inst Nz Ltd | Sustained release bolus for ruminants |
| US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
| AUPN353695A0 (en) | 1995-06-14 | 1995-07-06 | Commonwealth Scientific And Industrial Research Organisation | Immunogenic preparation and method for improving the productivity of ruminant animals |
| WO1998007830A2 (en) * | 1996-08-22 | 1998-02-26 | The Institute For Genomic Research | COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII) |
| US5985907A (en) * | 1998-08-12 | 1999-11-16 | Health Research, Inc. | Method for inhibiting growth of methanogens |
| WO2002077183A2 (en) * | 2001-03-21 | 2002-10-03 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| WO2003038109A2 (en) | 2001-09-18 | 2003-05-08 | The Board Of Regents Of The University Of Nebraska | Method for the inhibition of methanogenesis |
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
| WO2003076575A2 (en) * | 2002-03-04 | 2003-09-18 | Fidelity Systems, Inc., Et Al. | The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| SE523209C2 (sv) * | 2002-05-14 | 2004-04-06 | Akzo Nobel Nv | Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur |
| WO2006102350A1 (en) | 2005-03-23 | 2006-09-28 | Washington University In St. Louis | The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota |
| NZ745324A (en) * | 2007-09-25 | 2023-02-24 | Pastoral Greenhouse Gas Res Ltd | Vaccines and vaccine components for inhibition of microbial cells |
| CN101434924A (zh) * | 2008-12-17 | 2009-05-20 | 中南大学 | 一种分离严格厌氧产甲烷古菌的方法 |
| AU2010287069B2 (en) * | 2009-08-27 | 2016-07-07 | Lucidome Bio Limited | Complete genome sequence of the methanogen Methanobrevibacter ruminantium |
| CN101864362B (zh) * | 2010-05-19 | 2012-05-09 | 江苏加德绿色能源有限公司 | 一种复合微生物菌剂及其应用 |
| DE102011119230B4 (de) * | 2011-11-23 | 2013-07-11 | Audi Ag | Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte |
| EP2935364A2 (en) * | 2012-12-21 | 2015-10-28 | Danisco US Inc. | Production of isoprene, isoprenoid, and isoprenoid precursors using an alternative lower mevalonate pathway |
-
2008
- 2008-09-25 NZ NZ745324A patent/NZ745324A/en unknown
- 2008-09-25 EP EP17206527.8A patent/EP3327030B1/en active Active
- 2008-09-25 CN CN200880109364.6A patent/CN101918431B/zh active Active
- 2008-09-25 BR BR122021010729-7A patent/BR122021010729B1/pt active IP Right Grant
- 2008-09-25 AR ARP080104173A patent/AR068553A1/es active IP Right Grant
- 2008-09-25 BR BRPI0817299A patent/BRPI0817299A8/pt not_active Application Discontinuation
- 2008-09-25 EP EP21181143.5A patent/EP3936516A1/en active Pending
- 2008-09-25 EP EP08834203.5A patent/EP2203466B1/en active Active
- 2008-09-25 CA CA2700164A patent/CA2700164C/en active Active
- 2008-09-25 CN CN2008801094507A patent/CN102015755A/zh active Pending
- 2008-09-25 CN CN201611216760.1A patent/CN107129524B/zh active Active
- 2008-09-25 AU AU2008304018A patent/AU2008304018A1/en not_active Abandoned
- 2008-09-25 EP EP08833501A patent/EP2203470A4/en not_active Ceased
- 2008-09-25 CL CL2008002860A patent/CL2008002860A1/es unknown
- 2008-09-25 RU RU2010116163/10A patent/RU2528854C2/ru not_active IP Right Cessation
- 2008-09-25 DK DK17206527.8T patent/DK3327030T3/da active
- 2008-09-25 JP JP2010526839A patent/JP5558356B2/ja not_active Expired - Fee Related
- 2008-09-25 UY UY31360A patent/UY31360A1/es not_active Application Discontinuation
- 2008-09-25 WO PCT/NZ2008/000247 patent/WO2009041830A2/en not_active Ceased
- 2008-09-25 CL CL2008002861A patent/CL2008002861A1/es unknown
- 2008-09-25 DK DK08834643.2T patent/DK2203467T3/en active
- 2008-09-25 WO PCT/NZ2008/000248 patent/WO2009041831A1/en not_active Ceased
- 2008-09-25 JP JP2010526840A patent/JP5552053B2/ja not_active Expired - Fee Related
- 2008-09-25 CN CN200880109156.6A patent/CN101932595B/zh active Active
- 2008-09-25 BR BR122021010737-8A patent/BR122021010737B1/pt active IP Right Grant
- 2008-09-25 DK DK08834203.5T patent/DK2203466T3/en active
- 2008-09-25 CL CL2008002859A patent/CL2008002859A1/es unknown
- 2008-09-25 AR ARP080104171A patent/AR068551A1/es unknown
- 2008-09-25 AR ARP080104172A patent/AR068552A1/es unknown
- 2008-09-25 JP JP2010526841A patent/JP6067209B2/ja active Active
- 2008-09-25 EP EP08834643.2A patent/EP2203467B1/en active Active
- 2008-09-25 MX MX2010003321A patent/MX2010003321A/es active IP Right Grant
- 2008-09-25 US US12/678,936 patent/US8592556B2/en active Active
- 2008-09-25 BR BRPI0817312-5A patent/BRPI0817312B1/pt active IP Right Grant
- 2008-09-25 MX MX2010003328A patent/MX2010003328A/es active IP Right Grant
- 2008-09-25 BR BR122020023381-8A patent/BR122020023381B1/pt active IP Right Grant
- 2008-09-25 MX MX2010003319A patent/MX340736B/es active IP Right Grant
- 2008-09-25 AU AU2008305846A patent/AU2008305846A1/en not_active Abandoned
- 2008-09-25 US US12/678,925 patent/US8586709B2/en active Active
- 2008-09-25 WO PCT/NZ2008/000249 patent/WO2009041832A2/en not_active Ceased
- 2008-09-25 UY UY31361A patent/UY31361A1/es active IP Right Grant
- 2008-09-25 ES ES17206527T patent/ES2895908T3/es active Active
- 2008-09-25 US US12/678,976 patent/US9296789B2/en active Active
- 2008-09-25 CA CA2700129A patent/CA2700129C/en active Active
- 2008-09-25 ES ES08834203.5T patent/ES2587595T3/es active Active
- 2008-09-25 AU AU2008304019A patent/AU2008304019A1/en not_active Abandoned
- 2008-09-25 ES ES08834643.2T patent/ES2625144T3/es active Active
- 2008-09-25 UY UY31359A patent/UY31359A1/es not_active Application Discontinuation
- 2008-09-25 CA CA2700162A patent/CA2700162C/en active Active
-
2010
- 2010-03-18 ZA ZA2010/01933A patent/ZA201001933B/en unknown
-
2013
- 2013-10-25 US US14/063,640 patent/US20140220636A1/en not_active Abandoned
-
2014
- 2014-07-04 JP JP2014139171A patent/JP2015042166A/ja active Pending
- 2014-08-08 AU AU2014210649A patent/AU2014210649B2/en active Active
-
2016
- 2016-03-28 US US15/082,373 patent/US10590170B2/en active Active
- 2016-10-05 JP JP2016197575A patent/JP2017046704A/ja active Pending
-
2020
- 2020-02-10 US US16/786,665 patent/US10995120B2/en active Active
-
2021
- 2021-04-08 US US17/226,028 patent/US11926647B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008002859A1 (es) | Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana. | |
| MX2022009512A (es) | Alteracion dirigida del receptor celular del complejo mayor de histocompatibilidad (mhc). | |
| CL2018001110A1 (es) | Mutaciones de punto en cáncer resistente a inhibidor de trk y métodos relacionados con el mismo | |
| MX2018007061A (es) | Composiciones y metodos para enzimas de internalizacion. | |
| MX2022009478A (es) | Compuestos y metodos para degradacion mejorada de proteinas y otros polipeptidos elegidos como blanco mediante una ubiquitina ligasa e3. | |
| EA201201036A1 (ru) | Целевые геномные изменения | |
| GB2557153A (en) | Methods and compositions for detecting a target RNA | |
| BR112019000693A2 (pt) | composições de muc1- car e métodos para uso | |
| EP4368992A3 (en) | Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue | |
| BR112012026379A2 (pt) | métodos para gerar proteína endogenamente marcada | |
| EA201401319A1 (ru) | Способы и композиции рнк-специфической модификации днк-мишении рнк-специфической модуляции транскрипции | |
| ES2691070T3 (es) | Péptidos antiinflamatorios y composición que comprende los mismos | |
| WO2013059582A3 (en) | Small molecule inhibitors of histone deacteylases | |
| MX2010004674A (es) | Variantes de alfa-amilasa con propiedades alteradas. | |
| BRPI1011934A8 (pt) | Composição | |
| PH12016500395A1 (en) | Cell penetrating conjugates and methods of use thereof | |
| MX2019010039A (es) | Composiciones y métodos para transducción de tumores. | |
| EP2516624A4 (en) | CELL LINE 3M | |
| EP4269427A3 (en) | Protein interfaces | |
| EP4235179A3 (en) | Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker | |
| CL2008001762A1 (es) | Polinucleotidos codificantes para proteinas con actividad nitrato reductasa, vector, casete de expresion y celula huesped que comprenden dichos acidos nucleicos; y metodo para incrementar el rendimiento de una planta. | |
| BRPI0921371A2 (pt) | Células-tronco para uso terapêutico que são derivados de monócito humano, e método para induzir as mesmas. | |
| WO2019028422A9 (en) | METHODS OF ACTIVATION OF IMMUNE CELLS | |
| EA201000864A1 (ru) | Фенилоксетанильные производные | |
| ATE556446T1 (de) | Batterieanoden |